Skip to main content
Novacyt logo

Novacyt — Investor Relations & Filings

Ticker · ALNOV ISIN · FR0010397232 LEI · 213800BWAC2BF295EG28 PA Manufacturing
Open in API
Filings indexed 1,101 across all filing types
Latest filing 2024-08-01 Transaction in Own Shar…
Country FR France
Listing PA ALNOV

About Novacyt

https://novacyt.com/

Novacyt is an international molecular diagnostics company that provides a broad portfolio of integrated technologies and services. The company's core activities include the design, development, manufacturing, and commercialization of in vitro and molecular diagnostic tests, with a specialization in real-time PCR (qPCR) kits and reagents. Novacyt's solutions are applied across various markets, including clinical diagnostics for human health, with a focus on infectious diseases and oncology, as well as animal health and food safety. The company also offers custom development services, contract manufacturing, and pharmaceutical research services such as whole genome sequencing.

Recent filings

Filing Released Lang Actions
Liquidity Agreement and Total Voting Rights
Transaction in Own Shares Classification · 99% confidence The document is an official announcement released via RNS (RNS Number: 8464Y) on August 1, 2024. The content explicitly details a 'Liquidity Agreement Monthly Update' concerning share purchases/sales by a third party (Invest Securities) and provides the 'Total Voting Rights' as of July 31, 2024. This type of regular, mandatory disclosure regarding share capital structure, treasury shares, and total voting rights, often linked to liquidity agreements or regulatory requirements (like Article L. 223-7 of the French Commercial Code), fits best under the general category of regulatory announcements that are not specific financial reports (10-K, IR) or management changes (MANG). Since it is a formal, periodic regulatory update that doesn't fit the more specific categories like DIV, DIRS, or CAP, the most appropriate classification is the general regulatory filing category, RNS.
2024-08-01 English
Half Year Trading Update
Earnings Release Classification · 99% confidence The document is titled 'Half Year Trading update' and provides 'unaudited trading update for the six months ended 30 June 2024'. This content, focusing on financial highlights for a period shorter than a full year (H1 2024), strongly indicates an Interim/Quarterly Report. However, the document is distributed via RNS (indicated by 'RNS Number : 7486X' and the closing boilerplate) and presents only the key financial highlights and commercial progress, rather than the comprehensive financial statements typically found in a full Interim Report (IR). Furthermore, the document is relatively short (10,463 characters) and functions as an announcement of performance for the period. Since it is a periodic financial update announcement distributed through a regulatory news service, it fits best under the category of an Earnings Release (ER) which covers initial announcements of periodical financial results (key highlights only). While it covers a half-year period, the format is that of a trading update/release rather than the comprehensive 'Interim Report' (IR). Given the context of providing key financial highlights for a period, ER is the most appropriate classification for this announcement format. H1 2024
2024-07-25 English
Half Year Trading Update
Earnings Release Classification · 95% confidence The document is a 'Half Year Trading update' for Novacyt S.A. covering the six months ended 30 June 2024. It provides unaudited financial highlights (revenue, cash position) and operational updates. While it contains financial data, it is an initial announcement of results (a trading update) rather than a full interim financial report. According to the definitions, an Earnings Release (ER) covers the initial announcement of quarterly/periodical financial results, which fits this document perfectly. H2 2024
2024-07-25 English
Rapport semestriel d'activité
Interim / Quarterly Report Classification · 100% confidence The document is a 'Rapport semestriel d'activité' (Interim Activity Report) for Novacyt S.A. for the period ending June 30, 2024. It contains substantive financial data, including revenue figures, cash position, and operational updates. Although it mentions a previous RNS announcement, the document itself provides the full text of the interim report, thus qualifying as an Interim/Quarterly Report (IR) rather than just a publication announcement. H2 2024
2024-07-25 French
Result of AGM
AGM Information Classification · 99% confidence The document explicitly states it is an announcement regarding the 'Result of AGM' (Annual General Meeting). It mentions that 'all resolutions proposed at the ordinary general meeting part of the Company's Annual General Meeting (AGM), held today, were duly passed.' This directly corresponds to the definition of AGM Information (AGM-R). Although it is a regulatory filing (indicated by the RNS Number and LSE distribution), the specific content is the outcome of the AGM, making AGM-R the most precise classification.
2024-07-18 English
Result of AGM
AGM Information Classification · 99% confidence The document explicitly states "Result of AGM" in the main heading and details that all resolutions proposed at the Annual General Meeting (AGM) were duly passed. It also mentions subsequent board appointments following the AGM. This content directly relates to the proceedings and outcomes of the Annual General Meeting. Therefore, the appropriate classification is AGM Information (AGM-R). The document is not a simple announcement of a report (RPA/RNS) but the actual result summary.
2024-07-18 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.